Generic Labeling Rule Defies Predictions, Remains In FDA's Long-Term Pipeline
Executive Summary
Policy that would allow generic sponsors to change product labels has been delayed yet again, not spiked completely, even with Commissioner Gottlieb's known opposition to the rule.